Commentary: Novartis CEO: Gene therapy offers hope of cures in one treatment, but US needs new pricing and payment model

By 2025, the FDA expects to approve 10 to 20 new cell and gene therapies each year. I believe these therapies will eventually have the same extraordinary impact on health as other significant advances in medicine, such as improved cancer treatments that have contributed to 25 straight years of declining cancer deaths.